Latest Parkinson's disease Stories

Alim Louis Benabid, MD, PhD, Awarded 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research by The Michael J. Fox Foundation

2013-05-31 16:23:41

NEW YORK, May 31, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that Alim Louis Benabid, MD, PhD, is the recipient of the 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research. The prize recognizes an honoree's contribution to Parkinson's research as well as an exceptional commitment to mentoring the next generation of Parkinson's scientists. Professor Benabid, widely recognized as the inventor and pioneer of...

$1MM Gift to Support the Muhammad Ali Parkinson Center’s Mission of Hope & Healing

2013-05-29 23:19:28

The Bob & Renee Parsons Foundation Funds Fellowships & On-going Parkinson's Disease Research at Barrow Neurological Institute Scottsdale, AZ (PRWEB) May 29, 2013 The Bob & Renee Parsons Foundation has contributed $1 million to the Muhammad Ali Parkinson Center at Barrow Neurological Institute. The gift will support two fellowships in Parkinson’s disease plus additional staffing for the Center and research in the Gait and Balance Laboratory. Bob and Renee Parsons are...

Exposure To Pesticides Increases Risk Of Developing Parkinson's Disease

2013-05-28 13:29:26

Brett Smith for redOrbit.com - Your Universe Online In what might be considered cause for concern among farm workers – a new research review in the journal Neurology has found a link between Parkinson’s disease and exposure to chemical weed or bug killers. The review included over 100 studies from around the world and calculated between a 33 to 80 percent increased risk of developing the disorder as exposure to certain weed or bug killers increased. Prolonged exposure to the weed...

Boston Scientific Receives CE Mark Approval For GUIDE(TM) DBS System

2013-05-27 16:20:16

GUIDE DBS is the World's First Deep Brain Stimulation Visual Simulation System NATICK, Mass., May 27, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for use of the GUIDE(TM) DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians with 3D visualization information that simulates stimulation output, which may reduce programming time and enable more precise targeting of therapy. With...

NDI Launches Deep Brain Innovations, LLC

2013-05-24 23:26:56

Optimizing electrical stimulation to treat Parkinson's disease and other neurological conditions. Cleveland, OH and Durham, NC (PRWEB) May 23, 2013 NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with...

19th Parkinson's Unity Walk Raises More than $1.6 Million in Support of Parkinson's Research

2013-05-21 08:30:12

More than 10,000 Walkers Make Every Step Count in Raising Funds and Awareness for Parkinson's KINGSTON, N.J., May 21, 2013 /PRNewswire-USNewswire/ -- The Parkinson Alliance proudly announced today that the 19th Parkinson's Unity Walk held on Saturday, April 27, 2013 in New York City's Central Park, has thus far raised more than $1.6 million and united more than 10,000 walkers in raising awareness for Parkinson's disease and to support research for better treatments, and hopefully...

Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study

2013-05-21 08:28:22

Clinical Data on CERE-120 (AAV-NRTN) Presented at the 16th Annual Meeting of the American Society of Gene and Cellular Therapy (ASGCT) SAN DIEGO, May 21, 2013 /PRNewswire/ -- Ceregene, Inc. today announced additional efficacy data from a secondary analysis of its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin). CERE-120 is a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease. This exploratory...

Kinesia ProView Launches to Visualize Parkinson's Symptom Response to Deep Brain Stimulation Programming

2013-05-15 08:31:05

VALLEY VIEW, Ohio, May 15, 2013 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView(TM) [ http://www.glneurotech.com/kinesia/proview/index.php ] to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson's disease. Kinesia ProView provides a standardized platform to quantitatively assess how symptoms such as tremor, bradykinesia, and dyskinesias change in response to specific DBS...

The National Parkinson Foundation and Johns Hopkins University Address Disparities in Care Through Telemedicine

2013-05-13 08:29:05

--Recipients of $1.7 Million Award from Patient-Centered Outcomes Research Institute-- MIAMI, May 13, 2013 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) has approved a research award to the National Parkinson Foundation (NPF) and Johns Hopkins University to deliver telemedicine care to people with Parkinson's disease in their homes. E. Ray Dorsey, MD, Director, Johns Hopkins Parkinson's Disease and Movement Disorders Center is the lead...

Cancer Drug Prevents Build-Up Of Toxic Brain Protein

2013-05-10 11:57:50

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published online May 10 in Human Molecular Genetics, offers a unique and exciting strategy to treat neurodegenerative diseases that feature abnormal buildup of proteins in Parkinson's disease,...